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Dolichols are isoprenologues that are found in almost all tissues and whose biochemical function, aside from 
dolichol phosphate precursors, is not known. In addition, an understanding of the organizational and dy- 
namic properties of dolichols in biological membranes has not been forthcoming. The purpose of the experi- 
ments reported here were to examine the effects of dolichol on the physical properties of mouse synaptic 
plasma membranes (SPM). Differential polarized phase fluorometry indicated that dolichol both fluidized 
and regidified SPM. Membrane areas detected by diphenylhexatriene and trans-parinaric acid were selective- 
ly fluidized and rigidified, respectively. It also was found that the spin label, 5-doxyl stearic acid indicated 
that dolichol reduced membrane fluidity. These results report for the first time a stuctural effect of dolichol 
on a biological membrane. 
Dolichol Fluorometry ESR 
1. INTRODUCTION 
Free dolichol has been reported as a component 
of liver plasma membranes [I ,2] and brain mem- 
branes [3]. Accumulation of free dolichol in human 
and mouse brain is associated with aging [3-61 and 
with neuronal degenerative disorders such as neu- 
ronal ceroid-lipofuscinosis [3] and Alzheimer’s 
disease [7]. Several reports using electron spin 
resonance probes [8], fluorescence probes 191, dif- 
ferential scanning calorimetry [9,10], “P-NMR 
[lo], freeze fracture electron microscopy [lo] and 
X-ray scattering [lo] indicate that free dolichol 
(O-l mol%) dramatically fluidizes artificial model 
membranes and promotes formation of the non- 
bilayer hexagonal phase II form in phospholipids 
such as phosphatidylethanolamine. The purpose of 
the studies described here was to determine whether 
these findings are also relevant to a biological 
membrane, the synaptosomal plasma membrane 
(SPM). Differential polarized phase fluorometry 
Plasma membrane Isoprenolog 
indicated that membrane areas detected by diphen- 
ylhexatriene and trans-parinaric acid were selec- 
tively fluidized and rigidified, respectively, by 
dolichol. The fluorescent fatty acid data were in 
agreement with those using S-doxyl stearic acid 
and ESR techniques. These results report for the 
first time a structural effect of dolichol on a 
biological membrane. 
2. MATERIALS AND METHODS 
Bovine serum albumin, fatty acid free (BSA) 
and pig liver dolichol (98%) were purchased from 
Boehringer Mannheim, Indianapolis, IN and 
Sigma, St. Louis, MO, respectively. 1,6-Diphenyl- 
1,3$hexatriene and truns-parinaric acid were 
from Aldrich, Milwaukee, WI and Molecular 
Probes, Junction City, OR, respectively. 5-Doxyl 
stearic acid was from Sigma. 
Male C57BL/6NNIA (6 month old) mice were 
obtained from the National Institute on Aging 
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Colony maintained by Charles River, Wilmington, 
MA. Mice were housed, fed, killed by decapi- 
tation, brains dissected, and synaptosomal plasma 
membranes prepared by a method [ 1 l] modified as 
described in [12]. Dolichol was incorporated into 
synaptosomal plasma membranes (SPM) by first 
binding with BSA as follows. Dolichol, 66pg, was 
evaporated onto the bottom of an acid washed 
glass test tube. Then 250~1 of a 5% BSA solution 
in deionized water was added. The tube was de- 
gassed with Nz, sealed with teflon tape and a teflon 
cap, and placed in a 37°C shaking bath overnight. 
For the blank condition, a similar tube minus 
dolichol was set up. The BSA-dolichol or BSA 
solution was then transferred to a 10 ml polycar- 
bonate centrifuge tube containing 250 ,J (0.66 mg) 
SPM in phosphate-buffered saline (PBS), pH 7.2. 
This was then degassed, sealed with a teflon cap, 
and incubated with shaking at 37°C for 1 h. The 
sample was then diluted to 10 ml with PBS and 
sedimented at 40 000 x g for 20 min at 4°C with a 
40 Ti rotor on an L565B ultracentrifuge (Beckman, 
Fullerton, CA). The pellet was resuspended with 
10 ml PBS and again sedimented. 
The quantity of dolichol actually incorporated 
into SPM by the above method was determined by 
HPLC [4] after lipid extraction by the method of 
Folch [13]. 
1,6-Diphenyl-I ,3,5_hexatriene (DPH) and trans- 
parinaric acid were incorporated into SPM and all 
fluorescence parameters (lifetime, polarization, 
differential polarized phase fluorescence) were 
determined as described [ 141. Limiting anisotropy 
and rotational relaxation time (ns) were obtained 
according to Lakowicz et al. [ 151, basically as 
described in [14]. The order parameter for DPH 
was evaluated as (r.JrO)‘” [16]. All electron spin 
resonance procedures were performed as described 
]121. 
3. RESULTS AND DISCUSSION 
Although free dolichol is known to fluidize ar- 
tificial model phospholipid membranes, this effect 
has heretofore not been demonstrated in a biolo- 
gical membrane. The dolichol content of SPM 
from young (6 month old) mice, before and after 
exogenous dolichol incorporation, is 391 f 45 and 
3358 & 258 ng/mg protein, respectively. Thus only 
3.4% of the pig liver dolichol in the incubation 
26 
mixture is actually incorporated into the SPM. The 
level of dolichol observed in the untreated SPM 
compares favorably with that found in plasma 
membranes of liver and brain (300-1800 ng/mg 
protein) reported by others [l-3]. Most important, 
after treatment with exogenous dolichol, the level 
of dolichol found in SPM from 6 month old mice 
resembles that in SPM from 24 month old mice of 
the same strain, 3954 ng/mg protein. 
Dolichol significantly bcO.01) reduces the 
limiting anisotropy and order parameter of DPH 
in SPMs (table 1). This observation indicates that 
the resistance of the lipid microenvironment sur- 
rounding DPH to the motion of DPH is reduced 
due to dolichol incorporation. A reduction of 
DPH limiting anisotropy of 0.009 (table 1) in SPM 
is equivalent o raising the temperature of the SPM 
from 37.0 to 39.5”C. This reduction in limiting 
anisotropy is also equivalent to adding an intox- 
icating acute dose of ethanol (100 mM) to the SPM 
[ 171. Ethanol (160 mM) decreased the order para- 
meter of a spin labeled fatty acid about 0.8% [18] 
while herein dolichol decreases the order para- 
meter of DPH by 3.1%. In contrast to its effects 
on the structural or static properties of DPH in 
SPM, dolichol does not affect the rotational relaxa- 
tion time of DPH. Thus, dolichol affects the static 
but not dynamic aspects of DPH motion. A similar 
observation has been made for the effect of tem- 
perature on DPH motion in model membrane 
vesicles [ 151. 
In contrast to the results obtained with DPH, 
dolichol increases the limiting anisotropy and 
decreases the rotational relaxation time of the 
microenvironment occupied by trans-parinaric 
acid in the SPM (table 2). Thus, the resistance to 
trans-parinaric acid motion and the rate of rota- 
tion (the rate of rotation is equal to the reciprocal 
of 6x rotational relaxation time) increase. This 
result is confirmed by electron spin resonance 
measurements using 5-doxyl stearic acid, another 
type of fatty acid probe molecule (table 2). Doli- 
chol increases the order parameter or resistance to 
probe motion. 
In these studies, two important observations 
were made. First, the effects of dolichol on the 
physical properties of a biological membrane, the 
SPM, were reported for the first time. Second, 
dolichol had a two-fold effect, one of which dif- 
fered markedly from the results reported in ar- 
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Table 1 
Effect of dolichol on dynamic and static properties of fluorescence probe molecules 
in synaptosomal plasma membrane? 
Preincubation 
conditions 
Limiting 
anisotropy 
rca 
Rotational 
relaxation 
time 
(6R)-‘, ns 
Order 
parameter 
S 
1,6-Diphenyl-1,3,5_hexatriene 
BSA 0.190 * 0.001 1.23 f 0.03 0.700 f 0.003 
BSA-dolichol 0.181 + O.OOl* 1.26 + 0.09 0.678 f 0.003* 
Trans-Parinaric acidb 
BSA 0.161 f 0.002 2.26 + 0.14 - 
BSA-dolichol 0.188 f 0.003* 1.50 f 0.06* 
a Synaptosomal plasma membranes were isolated from mouse brain and probe 
molecules were incorporated as described in section 2. Values represent he mean f 
SE (n=3). An asterisk refers to ~~0.01 by Student’s t-test as compared to BSA 
pretreatment alone 
b Values for limiting anisotropy and rotational relaxation time of trans-parinaric acid 
refer to average values calculated from an intensity weighted average lifetime 
tificial model membranes. Namely, dolichol fluid- 
ized the lipid microenvironment of SPM sensed by 
DPH in a similar fashion as previously reported by 
a variety of techniques in membranes composed of 
artificial phospholipids [9, lo]. In contrast, free 
dolichol was not reported to rigidify any of these 
model membranes. Therefore, observation that 
dolichol increases the rigidity of the SPM lipid 
microenvironment surrounding the fatty acid 
probes (both fluorescence and ESR) demonstrates 
Table 2 
Effect of dolichol on electron spin resonance properties 
of 5-doxyl stearic acid in synaptosomal plasma 
membranes= 
Preincubation 
conditions 
BSA 
BSA-dolichol 
Probe molecule Order parameter 
S 
5-doxyl stearic 0.5958 + 0.045 
acid 
5-doxyl stearic 0.6156 f 0.0039* 
acid 
a All conditions were the same as described in the legend 
to table 1 except that 5-doxyl stearic acid and dolichol 
were concomitantly incorporated into the synap- 
tosomal plasma membrane followed by sedimentation 
and washing. Values represent he mean + SE (n = 4). 
An asterisk refers to p<O.Ol by Student’s t-test 
additional structural complexity in the biological 
membrane not reported in the artificial membrane 
systems. 
The dolichol content in brain is known to in- 
crease dramatically with age [ 1,4-61 and in diseases 
such as Alzheimers [l] and ceroid-lipofuscinosis 
[ 1,191. These changes may have differential effects 
on the membrane structure and on the lipid micro- 
environments of the SPM. Future investigations 
will clarify whether individual SPM functions may 
also be differentially regulated by dolichol, de- 
pending on the microenvironment wherein they 
reside. 
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